147 related articles for article (PubMed ID: 37950131)
61. Association between circulating adiponectin levels and polycystic ovarian syndrome.
Mirza SS; Shafique K; Shaikh AR; Khan NA; Anwar Qureshi M
J Ovarian Res; 2014 Feb; 7():18. PubMed ID: 24502610
[TBL] [Abstract][Full Text] [Related]
62. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
[TBL] [Abstract][Full Text] [Related]
63. Dehydroepiandrosterone sulfate/free androgen index ratio predicts a favorable metabolic profile in patients with polycystic ovary syndrome.
Nadir A; Temizkan S; Ozderya A; Temizkan O; Orbay E; Aydin K
Gynecol Endocrinol; 2019 Feb; 35(2):128-132. PubMed ID: 30324855
[TBL] [Abstract][Full Text] [Related]
64. Serum lipocalin-2 as an insulin resistance marker in patients with polycystic ovary syndrome.
Cakal E; Ozkaya M; Engin-Ustun Y; Ustun Y
J Endocrinol Invest; 2011 Feb; 34(2):97-100. PubMed ID: 20511727
[TBL] [Abstract][Full Text] [Related]
65. Vitamin D in polycystic ovary syndrome: Relationship to obesity and insulin resistance.
Joham AE; Teede HJ; Cassar S; Stepto NK; Strauss BJ; Harrison CL; Boyle J; de Courten B
Mol Nutr Food Res; 2016 Jan; 60(1):110-8. PubMed ID: 26255991
[TBL] [Abstract][Full Text] [Related]
66. Insulin resistance is not strictly associated with energy intake or dietary macronutrient composition in women with polycystic ovary syndrome.
Toscani MK; Mario FM; Radavelli-Bagatini S; Spritzer PM
Nutr Res; 2011 Feb; 31(2):97-103. PubMed ID: 21419313
[TBL] [Abstract][Full Text] [Related]
67. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
Deswal R; Nanda S; Dang AS
Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
[TBL] [Abstract][Full Text] [Related]
68. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
[TBL] [Abstract][Full Text] [Related]
69. Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS.
Phelan N; O'Connor A; Kyaw-Tun T; Correia N; Boran G; Roche HM; Gibney J
J Clin Endocrinol Metab; 2010 Aug; 95(8):3933-9. PubMed ID: 20519354
[TBL] [Abstract][Full Text] [Related]
70. Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome.
Liu S; Hu W; He Y; Li L; Liu H; Gao L; Yang G; Liao X
BMC Endocr Disord; 2020 May; 20(1):67. PubMed ID: 32429902
[TBL] [Abstract][Full Text] [Related]
71. Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome.
Alemzadeh R; Kichler J; Calhoun M
Eur J Endocrinol; 2010 Jun; 162(6):1093-9. PubMed ID: 20371657
[TBL] [Abstract][Full Text] [Related]
72. Prepregnancy Fat Free Mass and Associations to Glucose Metabolism Before and During Pregnancy.
Diaz EC; Børsheim E; Shankar K; Cleves MA; Andres A
J Clin Endocrinol Metab; 2019 May; 104(5):1394-1403. PubMed ID: 30496579
[TBL] [Abstract][Full Text] [Related]
73. Levels and changes in body mass index decomposed into fat and fat-free mass index: relation to long-term all-cause mortality in the general population.
Sørensen TIA; Frederiksen P; Heitmann BL
Int J Obes (Lond); 2020 Oct; 44(10):2092-2100. PubMed ID: 32518354
[TBL] [Abstract][Full Text] [Related]
74. Retinol-binding protein in nonobese women with polycystic ovary syndrome.
Lee JW; Im JA; Lee DC; Lee HR; Shim JY
Clin Endocrinol (Oxf); 2008 May; 68(5):786-90. PubMed ID: 17986278
[TBL] [Abstract][Full Text] [Related]
75. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
[TBL] [Abstract][Full Text] [Related]
76. Serum AMH levels and insulin resistance in women with PCOS.
Sahmay S; Aydogan Mathyk B; Sofiyeva N; Atakul N; Azemi A; Erel T
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():159-164. PubMed ID: 29605710
[TBL] [Abstract][Full Text] [Related]
77. Screening for a Simple and Effective Indicator of Insulin Resistance in Chinese Reproductive-Aged Women, with the Insulin Clamp Technique as a Reference.
Long J; Li L; Wang F; Yang G; Cheng W; Wei J; Chen M; Liu D
Metab Syndr Relat Disord; 2019 Oct; 17(8):423-429. PubMed ID: 31305214
[No Abstract] [Full Text] [Related]
78. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
79. Serum vaspin and C-reactive protein levels in women with polycystic ovaries and polycystic ovary syndrome.
Cakal E; Ustun Y; Engin-Ustun Y; Ozkaya M; Kilinç M
Gynecol Endocrinol; 2011 Jul; 27(7):491-5. PubMed ID: 20626239
[TBL] [Abstract][Full Text] [Related]
80. Lipid Accumulation Product (LAP) and Visceral Adiposity Index (VAI) as Markers of Insulin Resistance and Metabolic Associated Disturbances in Young Argentine Women with Polycystic Ovary Syndrome.
Abruzzese GA; Cerrrone GE; Gamez JM; Graffigna MN; Belli S; Lioy G; Mormandi E; Otero P; Levalle OA; Motta AB
Horm Metab Res; 2017 Jan; 49(1):23-29. PubMed ID: 27571188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
